That will end the federal conflict with state medical cannabis programs. Blumenauer’s bill, titled the States’ Medical Marijuana Patient Protections Act (HR 689), will move cannabis out of Schedule 1 of the Controlled Substances Act and allow for medical research to be controlled by an agency other than the National Institute of Drug Abuse. Farr’s bill, the Truth in Trials Act (HR 710), will allow patients, caregivers and providers who are in compliance with state law to offer evidence of the medical necessity for their use of cannabis.
See ASA’s Press Release for more information on the new bills!
Please take a minute to urge your Representative in the House to cosponsor HR 689, the States’ Medical Cannabis Patient Protection Act, and HR 710, the Truth in Trials Act today!